Prostaglandin e receptor 4 antagonists

TW202635654AInactive Publication Date: 2026-09-01NATIONAL HEALTH RESEARCH INSTITUTE

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114150707
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-12-24
Filing Date: 2025-12-23
Publication Date: 2026-09-01
Estimated Expiration: Not applicable · inactive patent

Application Information

Patent Timeline

24 Dec 2024

Priority

23 Dec 2025

Application

TW114150707

01 Sep 2026

Publication

TW202635654A

IPC: C07D413/12; C07D231/14; C07D401/12; C07D403/12; C07D405/12; C07D405/14; C07D409/12; C07D417/12; C12N5/071; C12N5/0775; C12N5/0797; C12N5/095

Inventors: 鄒倫; 李華容

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The compounds of Formula (I):Each variable is defined. Also disclosed is method of producing secresomes enriched for proteins or mRNAs using such compounds.

Need to check novelty before this filing date? Find Prior Art